ASTA Comments to FDA on Voluntary Sesame Labeling Guidance
ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
Multi-Industry Industry Letter to Congressional Appropriators in Support of CDC Food Safety Funding
In April 2026, ASTA signed onto a multi-industry letter to Congressional leaders on the Appropriations Subcommittee on Labor, Health, and Human Services, Education, and Related Agencies, urging for continued funding to support the Foodborne Diseases Active Surveillance Network (FoodNet), the only active foodborne illness surveillance network in the United States, as well as other food safety work at the Centers for Disease Control & Prevention (CDC).
Scientific Review of FDA's Draft Risk Profile on Spices
This document is a letter from February 2014 from James S Dickson to ASTA containing a scientific review of the FDA's Draft Risk Profile on Spices.
